Clinical trials
Terminated Phase 2 COVID-19 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
166 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2020 | 101 |
| 2021 | 48 |
| 2022 | 12 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 166 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Revimmune | 5 |
| Massachusetts General Hospital | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| Ampio Pharmaceuticals. Inc. | 2 |
| Charite University, Berlin, Germany | 2 |
| Columbia University | 2 |
| Corewell Health East | 2 |
| Hackensack Meridian Health | 2 |
| Johns Hopkins University | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 166 |
| Coronavirus Infections | 38 |
| Respiratory Distress Syndrome | 13 |
| Cytokine Release Syndrome | 10 |
| Severe Acute Respiratory Syndrome | 10 |
| Pneumonia | 7 |
| Lymphopenia | 6 |
| Pneumonia, Viral | 5 |
| Respiratory Tract Infections | 4 |
| Virus Diseases | 4 |
Trials
Showing 1 to 25 of 166. Each trial links to its page on Pharma Observatory.
66 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.